PDL BioPharma Inc (PDLI.OQ)
Tue, Feb 20 2018
* PDL BIOPHARMA TERMINATES INTEREST IN PURSUING ACQUISITION OF NEOS
* PDL Biopharma Inc files for non-timely 10-Q - SEC filing Source text: (http://bit.ly/2AC3Kyu) Further company coverage:
* PDL Biopharma's proposal to acquire Neos Therapeutics expires today; PDL urges Neos to provide update on sale process
* PDL Biopharma Inc announces third quarter 2017 financial results
U.S. drugmaker Neos Therapeutics Inc , which this week rejected a fourth takeover offer by PDL Biopharma Inc , will consider offers from other potential buyers, according to people familiar with the matter.
Oct 31 U.S. drugmaker Neos Therapeutics Inc , which this week rejected a fourth takeover offer by PDL Biopharma Inc, will consider offers from other potential buyers, according to people familiar with the matter.
* PDL Biopharma issues statement in response to Neos Therapeutics rejection of PDL acquisition proposal
* PDL Biopharma - Valeant to pay a one-time, lump-sum payment of $13.0 million as part of settlement
* Says confirmed it received unsolicited proposal from PDL Biopharma to buy co for $10.25 per share in cash
* PDL Biopharma proposes to acquire NEOS THERAPEUTICS for $10.25 per share in cash
- PDL BioPharma Has More Cash Than Its Market Cap
- Neos Therapeutics: Cotempla Off To A Strong Start
- Neos Therapeutics: Buyout Target?
- Biotech Forum Daily Digest: Revisiting Neos Therapeutics
- PDL BioPharma (PDLI) Presents At PiperJaffray 29th Annual Healthcare Conference - Slideshow
- Your Daily Pharma Scoop: A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tumbles